The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Discriminatory power of a 25-item distress screening tool CancerSupport Source: A cross-sectional study of 251 cancer survivors.
Melissa F Miller
No relevant relationships to disclose
C. Daniel Mullins
Consultant or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Janssen; Novartis; Pfizer
Honoraria - Bayer; Celgene; Pfizer
Research Funding - Amgen; Bayer; Pfizer
Ebere Onukwugha
Consultant or Advisory Role - Janssen
Christopher Gayer
No relevant relationships to disclose
Mitch Golant
No relevant relationships to disclose
Joanne S. Buzaglo
No relevant relationships to disclose